Abstract:The problem of studying cardiovascular diseases (CVD) for a long time remains extremely important, and, therefore, there are many works that offer new ways to diagnose and treat this group of diseases. Great opportunities are provided by the study of molecular interactions for a more accurate understanding of the pathogenesis of cardiovascular pathology. Many studies have recently been devoted to finding potential markers of CVD risk with the aim of more accurate and early diagnosis. In this review we analyze the latest literature data dedicated to the role of heat shock protein 70 (HSP70) in cardiovascular pathology. HSP70 take part in such processes as arterial hypertension, coronary heart disease, and atherosclerosis. In atherogenesis, serum heat shock proteins 70 play a major role. It has been proven that in patients with a high concentration of heat shock protein molecules circulating in the blood, increased values of the carotid intima-media complex were observed. The important role of antibodies to circulating HSP70 is noted. Found an association of high levels of these antibodies with atherosclerosis in patients with arterial hypertension in history, with myocardial infarction. Low levels of anti-HSP70 antibodies are observed in patients with acute coronary syndrome. This proves the complexity of the mechanism and the dual role of antibodies against serum heat shock proteins 70. Thus, antibodies against heat shock proteins 70 can be assessed as a protective marker, and as a predictor, which requires further study, and the HSP70 molecules themselves can somehow to participate in the development of cardiovascular pathologies. Much attention is paid to the role of the inflammatory process and the mechanisms of innate immunity in CVD. As it is currently believed that Danger-associated molecular patterns (DAMPs) are involved in the pathogenesis of these pathologies in the context of a “hazard/damage” model. According to this model, the triggering factor is stress, leading to the release of DAMPs and their binding to innate immunity receptors - Toll-like receptors (TLRs). Activation of TLRs triggers the signaling cascade in the cell leading to the synthesis of pro-inflammatory cytokines. This contributes to the development of inflammation, which can provoke the emergence of new pathological processes in the body and worsen the course of existing diseases. The identification of new potential markers and knowledge of the molecular mechanisms of the pathogenesis of CVD can play an important role in the development of a new individual approach to the prevention of cardiovascular diseases.

Emerging role of heat shock proteins in cardiovascular diseases

The Role of Extracellular Heat Shock Proteins in Cardiovascular Diseases

Heat-shock proteins and molecular chaperones: implications for pathogenesis, diagnostics, and therapeutics

Heat shock protein 60 and cardiovascular diseases: An intricate love‐hate story

The role of heat shock proteins and co-chaperones in heart failure

Heat Shock Proteins and their Protective Roles in Stem Cell Biology

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

Heat shock proteins: Cellular and molecular mechanisms in the central nervous system

Molecular chaperones and heat shock proteins in atherosclerosis

Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases

The heat shock response and small molecule regulators

Heat Shock Proteins: Cellular and molecular mechanisms in the CNS

THE ROLE OF THE HEAT SHOCK PROTEIN 70 IN THE PATHOGENESIS OF CARDIOVASCULAR PATHOLOGY

Current Understanding and Future Opportunities in Human Diseases

The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases

Heat Shock Proteins as Immunomodulants

The role and therapeutic potential of Hsp90, Hsp70, and smaller heat shock proteins in peripheral and central neuropathies

Heat shock protein paradigms in cancer progression: future therapeutic perspectives

Heat-shock proteins: new keys to the development of cytoprotective therapies

Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1

Role of the Heat Shock Protein Family in Bone Metabolism